JP2020503280A5 - - Google Patents

Download PDF

Info

Publication number
JP2020503280A5
JP2020503280A5 JP2019530099A JP2019530099A JP2020503280A5 JP 2020503280 A5 JP2020503280 A5 JP 2020503280A5 JP 2019530099 A JP2019530099 A JP 2019530099A JP 2019530099 A JP2019530099 A JP 2019530099A JP 2020503280 A5 JP2020503280 A5 JP 2020503280A5
Authority
JP
Japan
Prior art keywords
alkyl
cancer
aryl
chain
mitochondrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019530099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020503280A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/058508 external-priority patent/WO2018122789A1/en
Publication of JP2020503280A publication Critical patent/JP2020503280A/ja
Publication of JP2020503280A5 publication Critical patent/JP2020503280A5/ja
Priority to JP2022200267A priority Critical patent/JP7689690B2/ja
Pending legal-status Critical Current

Links

JP2019530099A 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用 Pending JP2020503280A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022200267A JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT109818 2016-12-29
PT10981816 2016-12-29
PCT/IB2017/058508 WO2018122789A1 (en) 2016-12-29 2017-12-29 Hydroxybenzoic acid derivatives, methods and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022200267A Division JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Publications (2)

Publication Number Publication Date
JP2020503280A JP2020503280A (ja) 2020-01-30
JP2020503280A5 true JP2020503280A5 (enExample) 2021-03-04

Family

ID=61074472

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019530099A Pending JP2020503280A (ja) 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用
JP2022200267A Active JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022200267A Active JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Country Status (8)

Country Link
US (1) US11078222B2 (enExample)
EP (1) EP3562830B1 (enExample)
JP (2) JP2020503280A (enExample)
KR (1) KR102750630B1 (enExample)
CN (1) CN110114365B (enExample)
BR (1) BR112019011303B1 (enExample)
CA (1) CA3048966A1 (enExample)
WO (1) WO2018122789A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3925961A4 (en) * 2019-10-30 2022-05-11 Fusion Biotechnology Co., Ltd. Mitochondria-targeting compound and composition comprising same for treating or preventing aging-related diseases
WO2023053059A1 (en) * 2021-09-30 2023-04-06 Universidade Do Porto Antifouling compound, method and uses thereof
WO2023220365A1 (en) * 2022-05-13 2023-11-16 Virginia Tech Intellectual Properties, Inc. Mitochondrial antioxidant treatment for cask-linked neurodevelopmental disorders
US20260097092A1 (en) * 2022-09-21 2026-04-09 Ulsan National Institute Of Science And Technology Pharmaceutical composition containing mitochondria-targeting compound as active ingredient for treating macular degeneration
KR102894216B1 (ko) * 2022-12-15 2025-12-18 울산과학기술원 Trap-1 억제제
CN116210697B (zh) * 2023-03-02 2024-05-14 西北农林科技大学 反式肉桂酸在提高苹果树腐烂病抗性中的应用
KR20250126454A (ko) * 2024-02-16 2025-08-25 울산과학기술원 암 세포의 티오에스테라제 및 활성산소종에 의해 자가 조립 중합되는 단량체 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2860266C (en) 2009-04-27 2017-10-31 Iowa State University Research Foundation, Inc. Neuroprotective compounds and their use
GB201320636D0 (en) * 2013-11-22 2014-01-08 Medical Res Council Compounds
MX2018010829A (es) * 2016-03-08 2019-02-07 Univ Michigan Regents Inductores de molécula pequeña de especies de oxígeno reactivo e inhibidores de la actividad mitocondrial.
US10913757B2 (en) * 2016-10-14 2021-02-09 Universidade Do Porto Hydroxycinnamic derivatives, methods and uses thereof

Similar Documents

Publication Publication Date Title
EP3833343B1 (en) Heterocyclic flavone derivatives, compositions, and methods related thereto
JP2023051961A5 (enExample)
EP3630101B1 (en) Tegavivint for use in the treatment of pulmonary fibrosis
TN2013000293A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
JP7341034B2 (ja) プロテオパチーの処置のためのベンジリデングアニジン誘導体の新規な治療的使用
MX2021006265A (es) Derivados de panteteina y usos de los mismos.
MX2018001196A (es) Compuesto derivado de amida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6 y composición farmacéutica que lo contiene.
NZ740429A (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
CA2851996A1 (en) Pharmaceutical compositions for substituted quinazolinones
SG11201806438UA (en) Fused Pyrazole Derivatives, Preparation Method Thereof, And Use Thereof In Treatment Of Cancers, Inflammation And Immune Diseases
KR20180058829A (ko) Ezh2 억제제로 수모세포종을 치료하는 방법
CN110114365B (zh) 羟基苯甲酸衍生物、方法及其用途
JP6243849B2 (ja) 口腔用組成物及び口腔用活性酸素消去剤
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ
AU2015204609B2 (en) Novel functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy
JP7405484B2 (ja) うつ病及び片頭痛の治療に使用される新規化合物
EP4226919A1 (en) Ferroptosis inhibitor
BR112019010816A2 (pt) composto de fórmula i, composto de fórmula ii, composto de fórmula iii, composto de fórmula iv, composto de fórmula v, composição farmacêutica, compostos, composto de fórmula viii, composto de fórmula ix, e composto de fórmula x
JP7798358B2 (ja) 癌の処置のためにタキサンと共にfabp5阻害剤を使用する併用療法
CN112654355A (zh) 用于骨骼肌调节的raf-1激酶抑制剂化合物、其方法和用途
JP2021105061A (ja) アミロイド線維形成の抑制又は阻害剤
WO2021069736A1 (en) New carbazole derivatives sensitizing cells to anti-cancer agents
US12343316B2 (en) Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases
US20220315544A1 (en) Uses of doxadiazines compounds
WO2017219086A1 (en) Anti-ageing compounds